Background: Vein graft failure after bypass surgery is greatly increase in patients with diabetes mellitus. The cellular mechanisms underlying the cause of this failure are largely unexplored. Protein kinase B/AKT is a mechanically sensitive regulator of cellular growth and apoptosis. Herein we examine whether diabetes affects the regulation of AKT in response to increased venous loading. Methods: Inferior venae cavae (IVC) from the non-diabetic lean (LNZ) and the diabetic obese syndrome X Zucker(OSXZ) rats were isolated and incubated ex vivo under basal or pressurized conditions (120 mmHg). Protein expression, basal activation and the ability of increased pressure to activate AKT3 and apoptosis-related signaling were evaluated by immunoblot analysis. Results: Compared to that seen in the non-diabetic lean animals, increased venous pressure in the OSXZ rats was not characterized by increases in APAF-1 concentration, XIAP proteolysis, AIF cleavage, or Bad phosphorylation. This evidence of decreased apoptotic signaling was associated with increased basal p-AKT3 levels (+136% ± 13% P < 0.05 higher in the OSXZ vs. LNZ IVC). Conclusion: These data suggest that diabetes-associated increases in p-AKT3 may alter the ability of the IVC to undergo pressure induced apoptosis-related signaling. Further investigation is required to determine whether these changes are associated with the increased vein graft attrition seen in the diabetic population.
Methods

Animals
All procedures were conducted in strict accordance with the Public Health Service policy on animal welfare. All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals as approved by the Council of the American Physiological Society and the Animal Use Review Board of Marshall University. Young (10 week, n = 12) male normal lean Zucker (non-diabetic, LNZ) (276 ± 19 g) and young (10 week, n = 12) male obese syndrome-X Zucker (diabetic, OSXZ) (347 ± 31 g) rats were obtained from the Charles River Laboratories and barrier housed one per cage in an AAALAC approved vivarium. Housing conditions consisted of a 12H: 12H dark-light cycle and temperature was maintained at 22˚C ± 2˚C. Animals were provided food and water ad libitum. Rats were allowed to recover from shipment for at least two weeks before experimentation during which time the animals were carefully observed and weighed weekly.
Materials
Antibodies against apoptotic protease activating factor 1 (APAF-1) [ [sc-11521] were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Precast 10% and 15% SDS-PAGE gels were procured from Lonza (Rockland, ME). Enhanced chemiluminescence (ECL) western blotting detection reagent was from Amersham Biosciences (Piscataway, NJ). Restore western blot stripping buffer was obtained from Thermo scientific (Rockford, IL) and 3T3 cell lysates were from Santa Cruz Biotechnology (Santa Cruz, CA). All other chemicals were purchased from Sigma (St. Louis, MO).
Inferior Venae Cavae Preparation
Rats were anesthetized with a ketamine-xylazine (4:1) cocktail (50 mg/kg ip) and supplemented as necessary for reflexive response. Collection and isolation of the inferior venae cavae were performed as described previously [8] . Inferior venae cavae were cannulated onto polystyrene tubing (outside diameter 3.0 mm; inner diameter 2.6 mm) with the aid of a dissection microscope. Mounted vessels were equilibrated, perfused, and subjected to 120 mm Hg of pressure for 30 minutes as described previously [8] .
Immunoblot Analysis
Vessels were immediately snap-frozen in liquid nitrogen at the end of each experiment. Protein isolates were prepared from collected venae cavae by pulverizing the samples under liquid nitrogen using a mortar and pestle and washed three times with ice cold phosphate buffered saline (PBS). T-PER (2 mL/1 g tissue weight) (Pierce, Rockford, IL) supplemented with 100 mM NaF, 1 mM Na 3 VO 4 , 2 mM PMSF 1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepsatin was used to extract proteins as detailed by the manufacturer. Samples were diluted to a concentration of 1.5 mg/mL in SDS-loading buffer and boiled for 5 minutes. Sample were separated on a 10% SDS-PAGE gel, transferred onto Hybond nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ) and interrogated with appropriate antibodies as previously described [8] .
Immunoprecipitation of AKT3
Tissue lysates (2 ug/ul) were precleared using protein A Sepharose beads for 1 h at 4˚C on a rotatory shaker. AKT3 antibody conjugated to magnetic beads was added to the lysate and incubated overnight at 4˚C with rotation. Beads were magnetically separated and heated in SDS sample buffer and ran on a SDS-PAGE (10%) for immunoblotting.
Data Analysis
Results are presented as mean ± SEM. Data were analyzed using the SigmaStat 3.0. A one-way analysis of variance (ANOVA) was performed for overall comparisons with the Student-Newman-Keuls post hoc test used to determine differences between groups. The level of significance accepted a priori was ≤ 0.05.
Results
Verification of Loading Stimulus
Light microscope analysis demonstrated no apparent differences in gross morphology between venae cavae obtained from lean and obese Zucker rats (data not shown). Isolated vessels responded to stretch in a passive manner (data not shown). Continuous recording of the vena cava loading pressure was monitored throughout the loading procedure. The vessel was immediately discarded if fluctuations in stretch induced loading occurred.
Diabetes Alters the Pressure-Induced Activation of AKT3.
The ratio of p-AKT (Thr308) to total AKT was not different between the LNZ and OSXZ animals (Figure 1(a) and Figure 1(d) ). The ratio of p-AKT (Ser 473) to total AKT was lower in the OSXZ IVC compared to that observed in the LNZ animals (28% ± 8%, P ≤ 0.05) (Figure 1(b) and Figure 1(d) ). The ratio of p-AKT (Ser 473) to total AKT was decreased with pressurization in the lean (31% ± 6%, P ≤ 0.05) but not OSXZ IVC (Figure  1(b) and Figure 1(d) ).
The ratio of p-AKT3 (Ser 473) to total AKT3 was higher in the OSXZ IVC (136% ± 13%, P ≤ 0.05) (Figure  1(c) and Figure 1(d) ) compared to the LNZ IVC. The ratio of p-AKT3 (Ser 473) to total AKT3 was unchanged in the LNZ IVC with loading (Figure 1(c) and Figure 1(d) ) and decreased in the OSXZ IVC (120% ± 16%, P ≤ 0.05) (Figure 1(c) and Figure 1(d) ).
Diabetes Attenuates Pressure Induced Cytochrome C Release into the Cytosol
Compared to observations in the IVC obtained from the lean animals, diabetes did not alter the cytosolic content of cytochrome-C. Pressurization of the IVC resulted in an increase in cytosolic cytochrome-C in both the lean (99% ± 9.9%, P ≤ 0.05) and obese (51% ± 14.7%, P ≤ 0.05); however, the obese response was significantly less than that seen in the lean animals (Figure 2) . † Significantly different from corresponding LNZ venae cavae (P ≤ 0.05), n = 6/group.
Diabetes Alters Regulation of Apoptotic Molecules in Pressurized Vena Cava
To investigate the influence of pressurization on the non-diabetes and diabetes on the expression and regulation of apoptotic associated proteins in the inferior venae cavae, we used immunoblotting to determine the total amount of APAF-1, AIF, and XIAP present in pressurized vena cava and non-pressurized (control) vena cava obtained from non-diabetic (LNZ) animals and diabetic (OSXZ) animals. Compared to observations in the lean IVC preparations, diabetes had no effect on the cytosolic expression of APAF-1 (Figure 3(a) ), however pressurization of the IVC in the control elicited an increase in cytosolic APAF-1 (196% ± 9.4%, P ≤ 0.05), whereas the pressurization in the diabetic IVC was not able to stimulate an increase in the cytosolic content of APAF-1 (Figure 3(a) ).
Compared to IVC preparations from lean animals, diabetes had no effect on the cytosolic content of AIF (67 kDa) or on AIF (sol) (57 kDa). Pressurization of the IVC obtained from lean animals resulted in an increase in the cytosolic content of AIF (32% ± 2.5%, P ≤ 0.05) and AIF (sol) (54% ± 8.8%, P ≤ 0.05) (Figure 3(b) and Figure 3(c) ). Pressurization in the diabetic IVC resulted in an increase in AIF (24% ± 6.0%, P ≤ 0.05) cytosolic content with no detectable cytosolic change in AIF (sol) (Figure 3(b) and Figure 3(c) ), however this induction of AIF was significantly less than seen in the lean animals.
When compared to lean, diabetes did not alter the expression of XIAP or any fragments of XIAP (Figures  4(a)-(c) ). Pressurization of the IVC from the lean and obese animals resulted in no change in XIAP expression. XIAP fragmentation was detected in pressurized IVC. Pressurization resulted in XIAP fragments of 45 kDa (338% ± 7.2%, p ≤ 0.05) when compared to non-pressurize IVC and 30 kDa (40% ± 9.5%, P ≤ 0.05) when compared to non-pressurized IVC in the lean, however in the obese only the 30 kDa fragment was detectable (30% ± 15.9%, P ≤ 0.05) (Figures 4(a)-(c) ). cavae from non-diabetic lean Zucker (LNZ) and diabetic obese syndrome X Zucker (OSXZ) rats. * Significantly different from unloaded venae cavae within the same group (P < 0.05). † Significantly different from corresponding non-diabetic venae cavae (P < 0.05). n = 6/group.
Discussion
Diabetes is associated with increased vein graft neointimal hyperplasia and higher graft failure rates [22] . The findings of this study, and our previous [8] , may provide insight as to why differences may exist. Consistent with our past study we found that elevated vascular loading in the LNZ IVC, but not the OSXZ IVC, were associated with evidence of increased apoptotic signaling. These findings may have clinical application as they suggest that OSXZ IVC may be "hard wired" to respond differently to mechanical stimuli than that seen in the normal, non-obese animals. Whether or not we might demonstrate similar findings with the use of human venous preparations awaits further experimentation.
One of the primary findings of this study was that insulin resistance appeared to be associated with the up regulation of AKT3 protein levels in the rat IVC. AKT3 is the third member of the AKT serine-threonine protein kinase family. It has been reported that AKT3 deficient mice have normal glucose metabolism and normal body weight but that they exhibit a reduction in brain mass [23] . The different roles that AKT3 may play in maintaining cellular function have yet to be fully characterized. AKT3 has been found to mediate resistance to apoptosis in melanoma cells [24] and undergo amplification in some types of human breast cancer [25] . Constitutively active AKT3 has also been shown to decrease doxorubicin-induced cleavage of caspase-3 [26] . Why AKT3 expression may be increased in the OSXZ IVC is currently unclear but may be related to elevations in blood insulin levels as hyperinsulinemia has been found to be associated with increased tumor formation [27] - [29] . Supporting this contention, the obese Zucker rat is not only hyperinsulinemic but it also shows an increased susceptibility to DMBA-induced mammary tumor development [30] . Previous research has indicated that AKT3 may play a room in mitochondrial biogenesis in endothelial cells [31] . It has also been reported that the ability of AKT3 to regulate mitochondrial dynamics may be due to AKT3 regulation of chromosome maintenance regioin-1 (CRM-1) dependent nuclear export [20] . One report has indicated that AKT3 maybe localized in both the nucleus and nuclear membrane where it is regulated [32] . Additionally in humans the AKT3 gene has been shown to have a strong association with angiogenesis and high altitude sickness [33] . Whether the increased AKT3 expression we observed in the OSXZIVC is a compensatory response to elevations circulating in sulin levels, as a preventive mechanism to prevent tumor development, or as an adaptive measure to ensure adequate mitochondrial function under conditions of diminished carbohydrate availability is currently unclear and will required additional study.
To examine if the alterations in AKT3 were associated with differences in apoptotic signaling we first examined how increased loading affected cytosolic cytochrome-C levels. With increased IVC pressurization we found evidence of diminished levels of cytosolic cytochrome-C, apoptotic protease activating factor 1 (APAF-1), decreased cleavage of apoptosis inducing factor (AIF), and reduced levels of cleaved X-linked inhibitor of apoptosis protein (XIAP) in the OSXZ IVC compared to that observed in the IVC samples obtained from the LNZ animals (Figure 4) . Cytochrome-C is a water soluble heme protein that is released from the mitochondria membrane into the cytosol where it assists APAF-1 and caspase-9 in forming the apoptosome [34] . The AIF is a mitochondrial localized flavor protein that is released from the mitochondria where it then triggers chromatin condensation and DNA degradation. It is thought that release of AIF is regulated, at least in part, following its cleavage by the calcium-dependent protease, calpain [35] [36] . Similar to AIF, XIAP is also regulated by cleavage. When intact, XIAP functions to inhibit apoptotic cell death by binding to and inhibiting caspases 3, 7, and 9 [37] .
Conclusion
These data, taken together, are consistent with our previous data showing an absence of load-induced caspase-3 fragmentation in the pressurized diabetic IVC [8] , suggesting that insulin resistance may render the IVC resistant to load-induced apoptosis. Whether these apoptotic-related differences cellular signaling between LNZ and OSXZ IVC are due solely to changes in the regulation of AKT3 alone or via alterations in other signaling pathways is currently unclear and awaits further study.
